Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Por um escritor misterioso

Last updated 24 março 2025

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease - Xu - 2019 - ChemistrySelect - Wiley Online Library

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

RU2662559C1 - New inhibitor of glutaminyl cyclase and its use for treatment of lung and respiratory diseases - Google Patents

Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

PDF) The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions

IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Schematic drawing of QC inhibitor approach. pGlu-Aβ

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study, Alzheimer's Research & Therapy